Aquestive Therapeutics, Inc. (AQST) vs CytomX Therapeutics, Inc. (CTMX)
A side-by-side comparison of Aquestive Therapeutics, Inc. and CytomX Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AQST
Aquestive Therapeutics, Inc.
$4.48HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
CTMX
CytomX Therapeutics, Inc.
$2.53HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — AQST vs CTMX
growth of $100 · dividends reinvested · last 8yAQST -71.5% (-14.5%/yr)CTMX -90.1% (-25.1%/yr)AQST compounded faster over this window
AQST CTMX
AQST vs CTMX: by the numbers
- •AQST is the larger company ($562M vs $551M market cap).
- •Both run net losses; AQST's is the smaller (-144.63% vs -435.21% net margin).
- •CTMX grew revenue faster over the past five years (2.18% vs -0.58% CAGR).
Metrics side by side
Valuation
| Metric | AQST | CTMX |
|---|---|---|
| P/S ratio | 10.39 | 30.09 |
| P/B ratio | N/A | 1.82 |
Profitability
| Metric | AQST | CTMX |
|---|---|---|
| Gross margin | 67.04% | 98.63% |
| Operating margin | -156.36% | -29.35% |
| Net margin | -144.63% | -435.21% |
| ROE | N/A | -26.37% |
| ROIC | -45.62% | -25.42% |
Growth (annualized)
| Metric | AQST | CTMX |
|---|---|---|
| Revenue CAGR (5Y) | -0.58% | 2.18% |
| Total return CAGR (5Y) | 2.24% | -12.01% |
Frequently asked
- Which has grown faster, AQST or CTMX?
- Over the past five years, CTMX grew revenue faster — AQST at a -0.58% CAGR versus CTMX at 2.18%.
- How have AQST and CTMX total returns compared?
- Over the past 5 years, AQST delivered 2.24% and CTMX delivered -12.01% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.